LINDSAY DILBECK: Open Payments
NPI 1730366550 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,850 in 92 payments from 19 companies in 2025. Trend: 2023 $1,936 · 2024 $1,918 · 2025 $1,850
Food & beverage: $1,850
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 15 | $280 |
| ABBVIE INC. | 8 | $269 |
| UCB, Inc. | 16 | $252 |
| Amgen Inc. | 10 | $247 |
| Regeneron Healthcare Solutions, Inc. | 6 | $143 |
| LEO Pharma Inc. | 5 | $110 |
| PFIZER INC. | 5 | $81 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $77 |
| Incyte Corporation | 4 | $65 |
| Janssen Biotech, Inc. | 3 | $55 |
Products named: Zoryve, Bimzelx, OTEZLA, DUPIXENT, SKYRIZI, RINVOQ, CIBINQO, OPZELURA.
Industry payments across OK — which companies pay providers there.
